{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:15:27Z","timestamp":1784114127877,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006453","name":"Taisho Toyama Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.spinee.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T01:48:33Z","timestamp":1560131313000},"page":"1739-1745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased advanced glycation end products in hypertrophied ligamentum flavum of diabetes mellitus patients"],"prefix":"10.1016","volume":"19","author":[{"given":"Mohammad Hasib","family":"Maruf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasibullah","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidullah","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetomi","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2019.06.001_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00586-009-0919-7","article-title":"The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum","volume":"18","author":"Hansson","year":"2009","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2019.06.001_bib0002","first-page":"43","article-title":"The musculoskeletal effects of diabetes mellitus","volume":"50","author":"Wyatt","year":"2006","journal-title":"J Can Chiropr Assoc"},{"key":"10.1016\/j.spinee.2019.06.001_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMED.S39035","article-title":"Diabetes mellitus, a new risk factor for lumbar spinal stenosis: a case-control study","volume":"9","author":"Asadian","year":"2016","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.spinee.2019.06.001_bib0004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1302\/0301-620X.76B2.8113279","article-title":"Lumbar spinal stenosis and diabetes. Outcome of surgical decompression","volume":"76","author":"Cinotti","year":"1994","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.spinee.2019.06.001_bib0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.spinee.2019.06.001_bib0006","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bjo.85.6.746","article-title":"Advanced glycation: an important pathological event in diabetic and age related ocular disease","volume":"85","author":"Stitt","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.spinee.2019.06.001_bib0007","first-page":"1649","article-title":"Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus","volume":"143","author":"Nakamura","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.spinee.2019.06.001_bib0008","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1038\/s41598-017-13360-w","article-title":"Mechanical stress induces elastic fibre disruption and cartilage matrix increase in ligamentum flavum","volume":"7","author":"Hayashi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.spinee.2019.06.001_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/BSD.0b013e31820bb76e","article-title":"Cellularity and cartilage matrix increased in hypertrophied ligamentum flavum: histopathological analysis focusing on the mechanical stress and bone morphogenetic protein signaling","volume":"25","author":"Shafaq","year":"2012","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2019.06.001_bib0010","first-page":"98","article-title":"Comparison of histological changes in the ligamentum flavum from spinal canal stenosis patients with and without diabetes mellitus","volume":"7","author":"Ghadiri-Anari","year":"2015","journal-title":"IJDO"},{"key":"10.1016\/j.spinee.2019.06.001_bib0011","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00586-017-5315-0","article-title":"Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study","volume":"27","author":"Shemesh","year":"2018","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2019.06.001_bib0012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4055\/cios.2009.1.2.81","article-title":"The increased expression of matrix metalloproteinases associated with elastin degradation and fibrosis of the ligamentum flavum in patients with lumbar spinal stenosis","volume":"1","author":"Park","year":"2009","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.spinee.2019.06.001_bib0013","first-page":"328","article-title":"Expression of hypoxia-inducible factor 1 alpha and oligodendrocyte lineage gene-1 in cultured brain slices after oxygen-glucose deprivation","volume":"8","author":"Cui","year":"2013","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.spinee.2019.06.001_bib0014","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00776-011-0135-2","article-title":"Matrix metalloproteinase 13 in the ligamentum flavum from lumbar spinal canal stenosis patients with and without diabetes mellitus","volume":"16","author":"Cui","year":"2011","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.spinee.2019.06.001_bib0015","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","article-title":"The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control","volume":"108","author":"Cipollone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.spinee.2019.06.001_bib0016","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.febslet.2007.03.090","article-title":"Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes","volume":"581","author":"Nah","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.spinee.2019.06.001_bib0017","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.3259727","article-title":"Cachectin\/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling","volume":"240","author":"Vlassara","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.spinee.2019.06.001_bib0018","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5551\/jat.3590","article-title":"Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes","volume":"17","author":"Ishibashi","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.spinee.2019.06.001_bib0019","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/humrep\/det419","article-title":"Advanced glycation end products and their receptor contribute to ovarian ageing","volume":"29","author":"Stensen","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.spinee.2019.06.001_bib0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/derm.22028","article-title":"Advanced glycation end products: key players in skin aging?","volume":"4","author":"Gkogkolou","year":"2012","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.spinee.2019.06.001_bib0021","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1152\/japplphysiol.00670.2007","article-title":"Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle","volume":"103","author":"Haus","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.spinee.2019.06.001_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation end products: two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.spinee.2019.06.001_bib0023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(99)00038-6","article-title":"N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress","volume":"144","author":"Nerlich","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.spinee.2019.06.001_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/ard.2004.034348","article-title":"Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings","volume":"65","author":"Hein","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.spinee.2019.06.001_bib0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","article-title":"Advanced glycation end products in the pathogenesis of chronic kidney disease","volume":"93","author":"Rabbani","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.spinee.2019.06.001_bib0026","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/00007632-199404150-00009","article-title":"Ligamenta flava in lumbar disc herniation and spinal stenosis. Light and electron microscopic morphology","volume":"19","author":"Postacchini","year":"1994","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2019.06.001_bib0027","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1097\/01.brs.0000188117.77657.ee","article-title":"Pathomechanism of ligamentum flavum hypertrophy: a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments","volume":"30","author":"Sairyo","year":"2005","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2019.06.001_bib0028","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s005860050181","article-title":"Histology of the ligamentum flavum in patients with degenerative lumbar spinal stenosis","volume":"8","author":"Schrader","year":"1999","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2019.06.001_bib0029","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00007632-199211000-00015","article-title":"Hypertrophied ligamentum flavum in lumbar spinal canal stenosis. Pathogenesis and morphologic and immunohistochemical observation","volume":"17","author":"Yoshida","year":"1992","journal-title":"Spine"},{"issue":"Suppl 1","key":"10.1016\/j.spinee.2019.06.001_bib0030","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.2119\/molmed.2015.00067","article-title":"Advanced glycation end products: a molecular target for vascular complications in diabetes","volume":"21","author":"Yamagishi","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.spinee.2019.06.001_bib0031","doi-asserted-by":"crossref","first-page":"E2466","DOI":"10.3390\/ijms18112466","article-title":"The role of glyoxalase-I (Glo-I), advanced glycation end products (AGEs), and their receptor (RAGE) in chronic liver disease and hepatocellular carcinoma (HCC)","volume":"18","author":"Hollenbach","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.spinee.2019.06.001_bib0032","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/hc0702.104183","article-title":"Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses","volume":"105","author":"Basta","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.spinee.2019.06.001_bib0033","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","article-title":"Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK","volume":"46","author":"Tanikawa","year":"2009","journal-title":"J Vasc Res"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943019307958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943019307958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:31:12Z","timestamp":1761514272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943019307958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1529943019307958"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2019.06.001","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased advanced glycation end products in hypertrophied ligamentum flavum of diabetes mellitus patients","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}